These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 17956913)

  • 21. Tissue preconditioning may explain concentric lesions in Baló's type of multiple sclerosis.
    Stadelmann C; Ludwin S; Tabira T; Guseo A; Lucchinetti CF; Leel-Ossy L; Ordinario AT; Brück W; Lassmann H
    Brain; 2005 May; 128(Pt 5):979-87. PubMed ID: 15774507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential macrophage/microglia activation in neocortical EAE lesions in the marmoset monkey.
    Merkler D; Böscke R; Schmelting B; Czéh B; Fuchs E; Brück W; Stadelmann C
    Brain Pathol; 2006 Apr; 16(2):117-23. PubMed ID: 16768751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clusters of activated microglia in normal-appearing white matter show signs of innate immune activation.
    van Horssen J; Singh S; van der Pol S; Kipp M; Lim JL; Peferoen L; Gerritsen W; Kooi EJ; Witte ME; Geurts JJ; de Vries HE; Peferoen-Baert R; van den Elsen PJ; van der Valk P; Amor S
    J Neuroinflammation; 2012 Jul; 9():156. PubMed ID: 22747960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acutely damaged axons are remyelinated in multiple sclerosis and experimental models of demyelination.
    Schultz V; van der Meer F; Wrzos C; Scheidt U; Bahn E; Stadelmann C; Brück W; Junker A
    Glia; 2017 Aug; 65(8):1350-1360. PubMed ID: 28560740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcription factor NF-kappaB and inhibitor I kappaBalpha are localized in macrophages in active multiple sclerosis lesions.
    Gveric D; Kaltschmidt C; Cuzner ML; Newcombe J
    J Neuropathol Exp Neurol; 1998 Feb; 57(2):168-78. PubMed ID: 9600209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of 'homeostatic' microglia and patterns of their activation in active multiple sclerosis.
    Zrzavy T; Hametner S; Wimmer I; Butovsky O; Weiner HL; Lassmann H
    Brain; 2017 Jul; 140(7):1900-1913. PubMed ID: 28541408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lesional accumulation of RhoA(+) cells in brains of experimental autoimmune encephalomyelitis and multiple sclerosis.
    Zhang Z; Schittenhelm J; Meyermann R; Schluesener HJ
    Neuropathol Appl Neurobiol; 2008 Apr; 34(2):231-40. PubMed ID: 17983427
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevated activity and microglial expression of myeloperoxidase in demyelinated cerebral cortex in multiple sclerosis.
    Gray E; Thomas TL; Betmouni S; Scolding N; Love S
    Brain Pathol; 2008 Jan; 18(1):86-95. PubMed ID: 18042261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safinamide and flecainide protect axons and reduce microglial activation in models of multiple sclerosis.
    Morsali D; Bechtold D; Lee W; Chauhdry S; Palchaudhuri U; Hassoon P; Snell DM; Malpass K; Piers T; Pocock J; Roach A; Smith KJ
    Brain; 2013 Apr; 136(Pt 4):1067-82. PubMed ID: 23518709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human endogenous retrovirus W in brain lesions: Rationale for targeted therapy in multiple sclerosis.
    van Horssen J; van der Pol S; Nijland P; Amor S; Perron H
    Mult Scler Relat Disord; 2016 Jul; 8():11-8. PubMed ID: 27456869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis.
    Noorbakhsh F; Tsutsui S; Vergnolle N; Boven LA; Shariat N; Vodjgani M; Warren KG; Andrade-Gordon P; Hollenberg MD; Power C
    J Exp Med; 2006 Feb; 203(2):425-35. PubMed ID: 16476770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amyloid precursor protein (APP) expression in multiple sclerosis lesions.
    Gehrmann J; Banati RB; Cuzner ML; Kreutzberg GW; Newcombe J
    Glia; 1995 Oct; 15(2):141-51. PubMed ID: 8567065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Iron Heterogeneity in Early Active Multiple Sclerosis Lesions.
    Tham M; Frischer JM; Weigand SD; Fitz-Gibbon PD; Webb SM; Guo Y; Adiele RC; Robinson CA; Brück W; Lassmann H; Furber KL; Pushie MJ; Parisi JE; Lucchinetti CF; Popescu BF
    Ann Neurol; 2021 Mar; 89(3):498-510. PubMed ID: 33244761
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Slow expansion of multiple sclerosis iron rim lesions: pathology and 7 T magnetic resonance imaging.
    Dal-Bianco A; Grabner G; Kronnerwetter C; Weber M; Höftberger R; Berger T; Auff E; Leutmezer F; Trattnig S; Lassmann H; Bagnato F; Hametner S
    Acta Neuropathol; 2017 Jan; 133(1):25-42. PubMed ID: 27796537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oxidative damage in multiple sclerosis lesions.
    Haider L; Fischer MT; Frischer JM; Bauer J; Höftberger R; Botond G; Esterbauer H; Binder CJ; Witztum JL; Lassmann H
    Brain; 2011 Jul; 134(Pt 7):1914-24. PubMed ID: 21653539
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of microglial TMEM119 and P2RY12 immunoreactivity in multiple sclerosis white and grey matter lesions is dependent on their inflammatory environment.
    van Wageningen TA; Vlaar E; Kooij G; Jongenelen CAM; Geurts JJG; van Dam AM
    Acta Neuropathol Commun; 2019 Dec; 7(1):206. PubMed ID: 31829283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Axonal expression of sodium channels and neuropathology of the plaques in multiple sclerosis.
    Bouafia A; Golmard JL; Thuries V; Sazdovitch V; Hauw JJ; Fontaine B; Seilhean D
    Neuropathol Appl Neurobiol; 2014 Aug; 40(5):579-90. PubMed ID: 23659577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunocytochemical characterization of the expression of inducible and constitutive isoforms of nitric oxide synthase in demyelinating multiple sclerosis lesions.
    De Groot CJ; Ruuls SR; Theeuwes JW; Dijkstra CD; Van der Valk P
    J Neuropathol Exp Neurol; 1997 Jan; 56(1):10-20. PubMed ID: 8990125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. "Microglial nodules" and "newly forming lesions" may be a Janus face of early MS lesions; implications from virus-induced demyelination, the Inside-Out model.
    Sato F; Martinez NE; Stewart EC; Omura S; Alexander JS; Tsunoda I
    BMC Neurol; 2015 Oct; 15():219. PubMed ID: 26499989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation of oligodendroglial progenitors in acute inflammatory demyelinating lesions of the rat brain stem is associated with demyelination rather than inflammation.
    Di Bello IC; Dawson MR; Levine JM; Reynolds R
    J Neurocytol; 1999; 28(4-5):365-81. PubMed ID: 10739577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.